- This event has passed.
Virtual 10th Annual Indiana CTSI Symposium on Disease and Therapeutic Response Modeling and Simulation Symposium
January 20 @ 8:00 am - 5:00 pm
REGISTRATION NOW OPEN!
Virtual 10th Annual Indiana CTSI Symposium on Disease and Therapeutic Response Modeling and Simulation Symposium
Wednesday, January 20 – Friday, January 22, 2021
Registration Link: https://go.iu.edu/3sd7
Given the wide array of challenges 2020 has given to us all, this year’s conference will be virtual. We are delighted to offer this year’s virtual conference at no charge to all attendees.
Speakers and Topics
| Speaker | Affiliation | Topic |
| Jessica Brady | Eli Lilly and Company | QSP-Informed novel target identification in Rheumatoid Arthritis |
| Nicholas Ellinwood | Eli Lilly and Company | QSP-Informed biomarker identification |
| Ruian Ke | Los Alamos National Laboratory | Dynamical modeling of SARS-CoV2 deposition and spread in lung and ensuing host response |
| Aleksandra Galetin | Center for Applied PK Research, University of Manchester | Mechanistic models as framework for understanding biomarker disposition: Prediction of creatinine-drug interactions |
| Alan Talevi | National University of La Plata | Machine learning application in virtual screening and computer-aided drug repurposing for neglected infectious diseases |
| Jane Bai | FDA | To be determined |
| Morgan Craig | Department of Mathematics and Statistics, University of Montreal | Modeling phenotypic switching in cancer |
| Paul Macklin | Luddy School of Informatics, Computing and Engineering, Indiana University | Multi-scale SARS-CoV2 infection and host response Modeling Consortium |
| Mohamed-Eslam Mohamed | AbbVie Inc. | To be determined |
| Matthew Rosebraugh | AbbVie Inc. | To be determined |
| Peter Bonate | Astellas | Extreme Value Theory for Pharmacometricians |
| Abhishek Gulati | Astellas | To be determined |
| Benjamin Kuzma | Massachusetts General Hospital | The dermal disposition of metronidazole and development of a Level A in vitro–in vivo relationship for topical dermatological drug products |
| Viswanath Devanarayan | GSK | Bioinformatics analysis of COVID-19 |
| Yana Vorontsova | Clinical Pharmacology and Modeling and Simulation Fellow, Indiana University School of Medicine | Application of natural language processing (NLP) to identify opiate abuse from electronic health records |
| Blessed Winston Arul Dhas | Modeling and Simulation Fellow, Indiana University School of Medicine | Population analysis of R- and S-methadone pharmacokinetics in pediatric patients |
| Larissa Lachi Silva | Modeling and Simulation Fellow, Indiana University School of Medicine | Population analysis of betamethasone pharmacokinetics in pregnancy |
| Tarunendu Mapder | Modeling and Simulation Fellow, Indiana University School of Medicine | Population of models in unlocking heterogeneity in disease manifestations |
| James Glazier | Department of Physics, Indiana University | Agent based modeling of SARS-CoV2 infection and host response |
| Rita de Almeida | Universidade Federal do Rio Grande do Sul | Multi-omics platform integration to support Bioinformatics analyses of host response to SARS-CoV infection |